Veterinary Medicines Information website

Gumboriffa ενέσιμο γαλάκτωμα για όρνιθες

Authorised
  • Infectious bursal disease virus, strain VNJO, Inactivated
Download as PDF

Product identification

Medicine name:
Gumboriffa ενέσιμο γαλάκτωμα για όρνιθες
Active substance:
  • Infectious bursal disease virus, strain VNJO, Inactivated
Target species:
  • Poultry
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain VNJO, Inactivated
    1000000.00
    50% cell culture infectious dose
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Poultry
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Poultry
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Complete application (stand-alone)
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 18565/14-02-2024/K-0125801
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 17/08/2026
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Greek (PDF)
Published on: 17/08/2026
Download